World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00927849
Date of registration: 23/03/2009
Primary sponsor: Mansoura University
Public title: Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy
Scientific title: Idiopathic Hypertensive Anal Canal: a Place of Internal Sphincterotomy
Date of first enrolment: September 2002
Target sample size: 63
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00927849
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
Egypt
Contacts
Name:   ayman elnakeeb, MD
Address: 
Telephone:
Email:
Affiliation:  mansoura university hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- all patients with hypertensive anal canal

Exclusion Criteria:

- patients who had any pathological anorectal lesions such as anal fissure, piles,
rectal prolapse, intussusception, anismus, cancer, patients with normal anal pressure

- patients who previously had anorectal surgery, chemical or surgical sphincterotomy,
anal dilatation, IBD, venereal disease, neurological disorder or systemic
gastrointestinal disease



Age minimum: 18 Years
Age maximum: 61 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Hypertensive Anal Canal
Intervention(s)
Drug: botulinum toxin injection (BTX A)
Drug: Glycerin trinitrate (GTN)
Procedure: lateral internal sphincterotomy (LIS)
Primary Outcome(s)
Effect of Closed Lateral Sphincterotomy and Chemical Sphincterotomy on Hypertensive Anal Canal [Time Frame: one year]
Relieve of Anal Pain [Time Frame: one year after the procedure]
Secondary Outcome(s)
Secondary ID(s)
hypertensive anal canal
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history